Pursuing Excellence in Xeno, Shaping Swine into Life-Giving Vessels, Sowing Blessings Across Humanity

Pursuing Excellence in Xeno, Shaping Swine into Life-Giving Vessels, Sowing Blessings Across Humanity

Millions wait for transplants — together, we can bring hope to life

Millions wait for transplants — together, we can bring hope to life

What is Xenotransplantation?

Concept

Transplanting animal-derived organs, tissues, or cells into humans


Types

Solid organs (e.g., kidney, liver, heart), biological tissues, and cellular therapies


Core Value

Addressing the critical global shortage of transplantable human organs

What is Xenotransplantation?
Why Choose Pigs for Xenotransplantation?

Pigs are considered ideal organ donors for xenotransplantation

  • Comparable organ size, and physiological compatibility with humans

  • High genetic tractability and rapid reproductive cycle

  • Lower ethical concerns compared to non-human primates, with manageable risk of zoonotic disease transmission

  • Well-established husbandry practices ensure a stable and reliable medical-grade organ supply

Why Choose Pigs for Xenotransplantation?
About ClonOrgan
China's Leading Xenotransplantation Enterprise

ClonOrgan is long-term dedicated to the in-depth R&D of xenotransplantation donor pigs;

Cultivating China's largest population of gene-edited, low-immunogenicity donor pigs;

Developing therapeutic technologies using transplantable pig organs and tissues, including kidneys, livers, hearts, skin, red blood cells.

  • Professor Dengke Pan

    Professor Dengke Pan

  • Professor Shaoping Deng

    Professor Shaoping Deng

News
Company News
Media Coverage
Science Outreach
Science Literature
  • 潘登科荣获“2026年四川省优秀共产党员” 称号

    2026/06/30 Company News
    在庆祝中国共产党成立105周年之际,经内江市委认真遴选、择优推荐,异种移植与再生四川省重点实验室主任、中科奥格创始人董事长潘登科同志被中共四川省委授予“2026年四川省优秀共产党员”称号。这份荣誉,是对一位科技工作者二十余年如一日坚守初心、勇攀高峰的礼赞,更是一家民营科技企业以党建铸他是“中国克隆猪第一人”,更是世界难题的破局者潘登科现任异种移植与再生四川省重点实验室主任、四川大学华西医院特聘研究...
  • 突破600天!中国异种肾移植临床前实验受体猴存活时间达到国际一流水平

    2026/06/21 Company News
    异种肾脏移植的长期有效,是备受关注的一个问题,需要在临床前非人灵长类试验观察。目前,仅美国的两个团队实现超过2年的存活时间。最新动态近日,中科奥格联合华中科技大学同济医学院附属同济医院等单位开展的异种肾移植临床前试验取得重大进展,基因编辑猪肾脏移植的受体猴已稳定存活超 600 天。截至目前,受体猴肾功能指标全部正常,末次检测血肌酐 94.8μmol/L,尿白蛋白阴性,移植肾脏功能状态平稳,有望突破...